Managing Toxicities Of Moxetumomab Pasudotox

Video

Chemotherapy is often associated with devastating toxicities, but moxetumomab pasudotox appears to be manageable based on the findings from a new trial.

At the 2019 Hairy Cell Leukemia Foundation Annual Conference, Robert J. Kreitman, MD, presented the combined findings of a phase I and phase III clinical trial of moxetumomab pasudotox associated with MRD negativity in patients with hairy cell leukemia. Findings showed that moxetumomab pasudotox was well tolerated among patients, and according to Kreitman, the drug did not show the typical toxicities associated with chemotherapy.

Kreitman, chief of the Clinical Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute, had the chance to sit down with OncLive®, a sister publication to Oncology Nursing News®, and discuss the toxicities they did see with moxetumomab pasudotox and what nurses and physicians can do to treat them.

TRANSCRIPTION

We really don't see the chemotherapy type toxicities. One of the things that we do see is mild headache and nausea, which can occur 6 to 12 hours after each of the three doses. And this is not a really severe toxicity, but it can be a problem, if patients are not going to drink water because they're having headaches or nausea, they don't feel like drinking. We find that getting a low dose of dexamethasone just 4mg orally knocks out this toxicity very quickly.

We also make sure that patients have that are available to them. They can take it right away, and they and if they don't feel like drinking because of those two things, then they can then then they can rapidly feel better and start drinking again. Oftentimes, the patients will get low-grade fevers as well, which can make the patients dehydrated and the dexamethasone can also get rid of that.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
Related Content